MA47607A - Synthèse à grande échelle d'arn messager - Google Patents

Synthèse à grande échelle d'arn messager

Info

Publication number
MA47607A
MA47607A MA047607A MA47607A MA47607A MA 47607 A MA47607 A MA 47607A MA 047607 A MA047607 A MA 047607A MA 47607 A MA47607 A MA 47607A MA 47607 A MA47607 A MA 47607A
Authority
MA
Morocco
Prior art keywords
arn
messenger
scale synthesis
synthesis
scale
Prior art date
Application number
MA047607A
Other languages
English (en)
Inventor
Jonathan Abysalh
Daniel Crawford
Frank Derosa
Anusha Dias
Michael Heartlein
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Publication of MA47607A publication Critical patent/MA47607A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1068Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1247DNA-directed RNA polymerase (2.7.7.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07006DNA-directed RNA polymerase (2.7.7.6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44773Multi-stage electrophoresis, e.g. two-dimensional electrophoresis
    • G01N27/44778Multi-stage electrophoresis, e.g. two-dimensional electrophoresis on a common gel carrier, i.e. 2D gel electrophoresis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Electrochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA047607A 2017-02-27 2018-02-27 Synthèse à grande échelle d'arn messager MA47607A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762464043P 2017-02-27 2017-02-27

Publications (1)

Publication Number Publication Date
MA47607A true MA47607A (fr) 2020-01-01

Family

ID=61800667

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047607A MA47607A (fr) 2017-02-27 2018-02-27 Synthèse à grande échelle d'arn messager

Country Status (10)

Country Link
US (2) US11560562B2 (fr)
EP (2) EP4105326A1 (fr)
AU (1) AU2018224325B2 (fr)
CA (1) CA3053814A1 (fr)
DK (1) DK3585886T3 (fr)
ES (1) ES2971902T3 (fr)
HU (1) HUE065140T2 (fr)
IL (2) IL310939A (fr)
MA (1) MA47607A (fr)
WO (1) WO2018157153A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012267578B2 (en) 2011-06-08 2017-04-20 Translate Bio, Inc. Cleavable lipids
EP3714048A1 (fr) 2017-11-22 2020-09-30 Modernatx, Inc. Polynucléotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'urée
WO2021127641A1 (fr) 2019-12-20 2021-06-24 Translate Bio, Inc. Procédé amélioré de préparation de nanoparticules lipidiques chargées d'arnm
CN115515559A (zh) 2019-12-20 2022-12-23 翻译生物公司 信使rna的直肠递送
WO2021163134A1 (fr) 2020-02-10 2021-08-19 Translate Bio, Inc. Procédés et compositions pour purification d'arn messager
CN115398546A (zh) 2020-02-18 2022-11-25 翻译生物公司 用于信使rna体外转录的改进方法
WO2021173840A1 (fr) 2020-02-25 2021-09-02 Translate Bio, Inc. Procédés améliorés de préparation de nanoparticules lipidiques chargées d'arnm
US20230190954A1 (en) 2020-05-07 2023-06-22 Translate Bio, Inc. Composition and methods for treatment of primary ciliary dyskinesia
CA3177940A1 (fr) 2020-05-07 2021-11-11 Anusha DIAS Sequences nucleotidiques optimisees codant pour des antigenes du sras-cov-2
JP2023526284A (ja) 2020-05-15 2023-06-21 トランスレイト バイオ, インコーポレイテッド mRNA送達のための脂質ナノ粒子製剤
CA3194863A1 (fr) 2020-10-06 2022-04-14 Shrirang KARVE Procede ameliore et formulation de nanoparticules lipidiques
US20220133631A1 (en) 2020-10-12 2022-05-05 Translate Bio, Inc. Process of preparing ice-based lipid nanoparticles
KR20230087536A (ko) 2020-10-12 2023-06-16 트랜슬레이트 바이오 인코포레이티드 Mrna-로딩된 지질 나노입자를 제조하는 개선된 프로세스
JP2023545503A (ja) * 2020-10-15 2023-10-30 トランスレイト バイオ, インコーポレイテッド メッセンジャーrnaの大規模合成
TW202233232A (zh) * 2020-11-06 2022-09-01 法商賽諾菲公司 遞送mRNA疫苗的脂質奈米顆粒
WO2022204549A1 (fr) 2021-03-25 2022-09-29 Translate Bio, Inc. Séquences nucléotidiques optimisées codant pour le domaine extracellulaire de la protéine ace2 humaine ou une portion de celle-ci
JP2024515668A (ja) 2021-04-19 2024-04-10 トランスレイト バイオ, インコーポレイテッド Mrnaの送達のための改善された組成物
WO2023278754A1 (fr) 2021-07-01 2023-01-05 Translate Bio, Inc. Compositions de livraison d'arnm
WO2023086893A1 (fr) 2021-11-10 2023-05-19 Translate Bio, Inc. Composition et méthodes de traitement de la dyskinésie ciliaire primitive
US20240043892A1 (en) * 2022-07-01 2024-02-08 Arcturus Therapeutics, Inc. Methods for in vitro transcription
WO2024112652A1 (fr) 2022-11-21 2024-05-30 Translate Bio, Inc. Compositions de formulations de poudre sèche d'arn messager et leurs procédés d'utilisation
WO2024126809A1 (fr) 2022-12-15 2024-06-20 Sanofi Arnm codant pour une particule de type virus de la grippe
WO2024133515A1 (fr) 2022-12-20 2024-06-27 Sanofi Vaccin contre l'arnm de rhinovirus
WO2024133884A2 (fr) 2022-12-23 2024-06-27 Sanofi Queue optimisée d'arn messager

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2735531T3 (es) 2005-08-23 2019-12-19 Univ Pennsylvania ARN que contiene nucleósidos modificados y métodos de uso del mismo
WO2009030254A1 (fr) 2007-09-04 2009-03-12 Curevac Gmbh Complexes d'arn et de peptides cationiques pour transfection et immunostimulation
DK2459231T3 (en) 2009-07-31 2016-09-05 Ethris Gmbh RNA with a combination of unmodified and modified nucleotides for protein expression
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
NZ700688A (en) 2009-12-01 2016-02-26 Shire Human Genetic Therapies Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
US8853377B2 (en) 2010-11-30 2014-10-07 Shire Human Genetic Therapies, Inc. mRNA for use in treatment of human genetic diseases
JP6184945B2 (ja) * 2011-06-08 2017-08-23 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド mRNA送達のための脂質ナノ粒子組成物および方法
ES2680595T3 (es) 2013-03-14 2018-09-10 Translate Bio, Inc. Evaluación cuantitativa para eficacia de ARN mensajero para tapar
EP2970955B1 (fr) 2013-03-14 2018-11-14 Translate Bio, Inc. Procédés de purification d'arn messager
ES2750661T3 (es) 2014-04-25 2020-03-26 Translate Bio Inc Métodos para la purificación de ARN mensajero
BR112016026980B1 (pt) * 2014-06-10 2022-05-03 Curevac Real Estate Gmbh Método para sintetizar uma molécula de rna de uma dada sequência
WO2016149508A1 (fr) 2015-03-19 2016-09-22 Shire Human Genetic Therapies, Inc. Thérapie d'arnm pour maladie de pompe
WO2016180430A1 (fr) * 2015-05-08 2016-11-17 Curevac Ag Procédé de production d'arn

Also Published As

Publication number Publication date
US20180258423A1 (en) 2018-09-13
AU2018224325B2 (en) 2024-05-02
HUE065140T2 (hu) 2024-05-28
IL268892A (en) 2019-10-31
ES2971902T3 (es) 2024-06-10
DK3585886T3 (da) 2024-02-19
IL268892B2 (en) 2024-07-01
IL268892B1 (en) 2024-03-01
IL310939A (en) 2024-04-01
AU2018224325A1 (en) 2019-09-12
EP4105326A1 (fr) 2022-12-21
EP3585886A1 (fr) 2020-01-01
CA3053814A1 (fr) 2018-08-30
EP3585886B1 (fr) 2023-11-22
US20240018514A1 (en) 2024-01-18
WO2018157153A1 (fr) 2018-08-30
US11560562B2 (en) 2023-01-24

Similar Documents

Publication Publication Date Title
MA47607A (fr) Synthèse à grande échelle d'arn messager
MA49421A (fr) Formulations d'arn
IL266212A (en) Direction for arrival assessment
IT201700062337A1 (it) Occhiali con dispositivi auricolari
MA46761A (fr) Administration sous-cutanée d'arn messager
MA42690A (fr) Micropropagation d'un dattier abada
MA53238A (fr) Formules d'ag10
IT201700074911A1 (it) Procedimento per la produzione di olefine da alcoli
IT201700035964A1 (it) “divisorio per boiserie”
UA41790S (uk) Блуза
IT201900025780A1 (it) Dispositivo per la produzione di idrogeno
IT201700112534A1 (it) Capo d'abbigliamento
IT201700088590A1 (it) Struttura di occhiali.
IT201700090331A1 (it) "lopemide"
IT201700071679A1 (it) Remembebe'
AU2016904636A0 (en) Direction of Arrival Estimation
AU2016904419A0 (en) Direction of Arrival Estimation
IT201700110269U1 (it) “Forno Bellavista”
IT201700123558A1 (it) Processo per la sintesi di 2-benzidril-3 chinuclidinone
IT201700034613A1 (it) Struttura di teleferica perfezionata
EP3523655A4 (fr) Dosages de point d'intervention
IT201700068126A1 (it) Struttura di filtropressa
UA36329S (uk) Комплект етикеток
UA36324S (uk) Комплект етикеток
UA35603S (uk) Сувенірний виріб «скрипка»